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Maternal separation (MS) is an early life stress model that induces permanent changes in the
central nervous system, impairing hippocampal long-term potentiation (LTP) and spatial
working memory. There are compelling evidences for a role of hippocampal adenosine A2A
receptors in stress-induced modifications related to cognition, thus opening a potential
window for therapeutic intervention. Here, we submitted rats to MS and evaluated the long-
lasting molecular, electrophysiological and behavioral impairments in adulthood. We then
assessed the therapeutic potential of KW6002, a blocker of A2A receptors, in stress-impaired
animals. We report that the blockade of A2A receptors was efficient in reverting the behavior,
electrophysiological and morphological impairments induced by MS. In addition, this effect is
associated with restoration of the hypothalamic-pituitary-adrenal axis (HPA-axis) activity, as
both the plasma corticosterone levels and hippocampal glucocorticoid receptor expression
pattern returned to physiological-like status after the treatment. These results reveal the
involvement of A2A receptors in the stress-associated impairments and directly in the stress
response system by showing that the dysfunction of the HPA-axis as well as the long-lasting
synaptic and behavioral effects of MS can be reverted by targeting adenosine A2A receptors.
These findings provide a novel evidence for the use of adenosine A2A receptor antagonists as
potential therapy against psychopathologies.
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Introduction
Exposure to stress has deleterious effects on brain
structure and function, which could be manifested
either immediately after stress,1 as a long-term
vulnerability to cognitive deficits2 or even as an
increased susceptibility to neuropsychiatric disor-
ders, where stress has a major role.3,4
Mother–infant interaction is a key factor for brain
maturation and disease susceptibility which in
humans can manifest in cognitive and behavioral
disorders later in life.5,6 In rats, the daily separation of
the litter from their mothers for 180min each day
during postnatal days (PNDs) 2–14 will result in an
alteration of maternal behavior, namely with a
significant reduction in licking/grooming duration.7
During this period, the hippocampus, which is
critically involved in long-term memory formation8
and is also a primary target for stress hormones in the
central nervous system,1,9 goes through great devel-
opment. The majority of hippocampal granule neu-
rons develop and extend their axons between PND 1
and 2110 and the peak period of neurogenesis and
mossy fiber outgrowth overlaps with the stress
hyporesponsive period (PND 4–14) in neonatal rats.11
This will induce changes that persist throughout
adult life at the level of gene expression, neurochem-
istry, electrophysiology proprieties and morphol-
ogy12,13 with behavioral and neuroendocrine signs
of cognitive deficits and over-activation of the
hypothalamic-pituitary-adrenal axis (HPA-axis) as
adults.7,14–16
Adenosine receptors in the hippocampus are
important modulators of synaptic transmission and
neuronal excitability. Glutamatergic synaptic trans-
mission in physiological conditions is controlled
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negatively by the dominant adenosine A1 receptors,
and positively to a lesser extent by A2A receptors.
17
Interestingly, this pattern appears to be modified in
the aged hippocampus, with a marked increase in the
expression of A2A receptors and a decrease in the
expression of A1 receptors.
18,19 These changes are
accompanied by a strong direct facilitatory effect of
A2A receptors on the release of glutamate.
20 This is
also observed in other situations associated to
neuronal dysfunction, such as epilepsy, acute stress
or animal models of Alzheimer’s disease,21 which
suggests a deleterious contribution of A2A receptors to
these conditions. The blockade of A2A receptors was
proven beneficial against synaptic loss associated
with acute stress in the hippocampus.22 Interestingly,
cognitive impairments also occur when excessive
levels of corticosteroids are attained due to disease, or
due to hypersecretion in response to a stressor.23,24
However, it is still unknown the extent to which
A2A receptors are involved in the long-term effects of
early life stress. Here, we submitted rats to maternal
separation (MS) and evaluated the long-lasting mole-
cular, electrophysiological and behavioral impair-
ments at adult age. We then assessed the therapeutic
potential of blocking endogenous activation of A2A
receptors, by administering a selective antagonist,
KW6002 (istradefylline), orally for 1 month to stress-
impaired animals. We report that the blockade of A2A
receptors was efficient in reverting the long-lasting
behavior, morphological and electrophysiological im-
pairments induced by MS. We also show that this
effect is associated with the re-establishment of the
HPA-axis activity, as both the plasma corticosterone
levels and hippocampal glucocorticoid receptor ex-
pression pattern returned to physiological-like status
after the treatment.
Materials and methods
Animals
Pregnant Wistar rats were purchased (Harlan, Barce-
lona, Spain) in mid-gestation and were due in our
animal facility. All animals were handled according
to European Community guidelines and Portuguese
law on animal care (1005/92). The animals that were
killed by decapitation were anesthetized under
halothane atmosphere.
MS protocol
The protocol used has been previously validated and
described.25 Wistar dams and their litters were
assigned either to the control (CTR—non-separated)
or to the MS groups as described before.26 To exclude
artifacts from genetic background, at PND 2, all the
litters were collected together, gender assessed and
the pups were randomly distributed to foster dams
(gender proportion maintained). MS pups were
removed from their cages as a group from PND 2 to
14, for 180min, daily, at 9 am, and placed in an
isolation cage in an adjacent room kept at
32.0±0.5 1C. At the end of the separation period,
pups were returned to their home-cage and rolled in
the soiled home cage bedding before reuniting with
the mother. CTR pups were not handled and were
maintained in their home-cages until weaning. At day
21 the pup’s gender was confirmed, males weaned
and housed in groups of 5–8 animals per cage until
use at adult age (8–14 weeks; according to diagram in
Supplementary Figure S1).
Oral administration of the drug
KW6002 (istradefylline), a selective adenosine A2A
receptor antagonist27 was orally administered diluted
in the drinking water, being continuously available.
The weight of the animals and the volume intake were
assessed twice a week and the concentration of the
solution was adjusted so that the drug intake was
maintained at 3mgkg–1 per day. Animals were
divided in four groups: CTR or MS, drinking vehicle
(0.025% methylcellulose) and CTR KW or MS KW
drinking KW6002 (3mgkg–1 per day, 0.025% methyl-
cellulose). The treatment started at 4–6 weeks old,
and was prolonged for 1 month until sacrifice. The
KW6002 administration was kept throughout the
behavioral assessments.
Corticosterone quantification
Blood was extracted from the tail, in animals
previously handled to minimize stress and without
anesthesia, at two different time points, 8 am (nadir)
and 8 pm (zenith). The plasma was isolated by
centrifugation at 2000 g, 4 1C for 15min and corticos-
terone quantified by radioimmunoassay using the rat
corticosterone 3H kit from MP Biomedicals, UK
according to the manufacturer’s protocol.
Behavioral assessments
CTR, MS, CTR KW, MS KW were first handled for 5
days before testing the behavior assays, that were
performed in the following sequence: open-field (OF),
Elevated plus maze (EPM) and Morris water maze
(MWM):28 Rats were given spatial acquisition training
consisting of four trials/day for 4 consecutive days, as
performed before.29 On the 5th day a probe test was
given in which the platform was removed and
animals were allowed to swim freely for 60 s while
recording the percentage of time spent on each
quadrant. The latency to found the platform during
acquisition and the percentage of time in the platform
quadrant in probe test were used to evaluate hipppo-
campal-dependent memory. EPM: The maze is
shaped like a plus sign and consists of two ‘open’
and two ‘closed’ arms, arranged perpendicularly, and
elevated 50 cm above the floor. Each animal was
placed at the center of the equipment, facing an open
arm. Each test lasted 5min and all testing sessions
were performed between 10:00 am and 17:00 pm in a
sound-attenuated room. The maze was cleaned with a
70% ethanol solution between each animal. The total
time spent in the open arms and the total arms entries
(number of entries in openþ closed arms) were used
as anxiety and locomotor measures.30 Open field:
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The animals were placed at the center of the arena
(66 66 cm) and allowed to explore for 5min.
Changes in mean speed and path length of the
subjects were continuously monitored by an auto-
mated tracking system (Smart 2.5, PanLab, Barcelona,
Spain). The maze was cleaned with a 70% ethanol
solution between each animal.
Histological procedures
The day after the last testing session, five rats from
each experimental group were perfused transcardially
with phosphate-buffered saline, under deep pento-
barbital anesthesia. Brains were removed and split
into two hemispheres, and processed either for
stereology, or for Golgi-Cox staining according to the
procedures previously described.31,32 Briefly, for
stereology the left hemispheres were included in
glycolmethacrylate (Tecnovit 7100; Heraeus Kulzer,
Werheim, Germany) and every other microtome-cut
section (30 mm) was then collected on a gelatinized
slide, stained with Giemsa, and mounted with
Entellan New (Merck, Darmstadt, Germany). The
shrinkage factor was calculated according to Madeira
et al.33 For 3D neuronal reconstructions, hemispheres
were removed and immersed in Golgi-Cox solution (a
1:1 solution of 5% potassium dichromate and 5%
mercuric chloride diluted 4:10 with 5% potassium
chromate34) for 14 days; hemispheres were then
transferred to a 30% sucrose solution (3 days), before
being cut on a vibratome. Coronal sections (200mm
thick) were collected in 6% sucrose and blotted dry
onto gelatin-coated microscope slides. They were
subsequently alkalinized in 18.7% ammonia, devel-
oped in Dektol (Kodak, Linda-a-Velha, Portugal),
fixed in Kodak Rapid Fix (prepared as manufacturer
instructions), dehydrated through a graded series of
ethanols, and cleared in xylene before being mounted
and coverslipped. Slides were coded before morpho-
metric analysis in both sets.
Region and layer boundaries
We analyzed the following regions of the hipocampal
formation: the dentate gyrus (including polymorphic,
granule cell layer and molecular layer), CA1 (strata
oriens, pyramidale, radiatum and lacunosum-mole-
culare) and CA3 (strata oriens, pyramidale, lucidum
and radiatum). The above-mentioned regions were
outlined according to the atlas of Paxinos and
Watson,35 based on noticeable cytoarchitectural
differences.36
Stereological procedures
Volume estimations were performed using StereoIn-
vestigator software (MicroBrightField, Williston, VT,
USA) and a camera (DXC390; Sony, Tokyo, Japan)
attached to a motorized microscope (Axioplan 2;
Zeiss, Oberkochen, Germany). Cavalieri’s principle37
was used to assess the volume of each region. Briefly,
every 10th section was used and its cross-sectional
area was estimated by point counting at a final
magnification of  112. For this, we randomly super-
imposed onto each area a test point grid in which the
interpoint distance, at tissue level, was as follows: (1)
150mm for the three layers of the dentate gyrus, (2)
250mm for the three layers of CA1 and CA3. The
volume of the region of interest was calculated from
the number of points that fell within its boundaries
and the distance between the systematically sampled
sections.
Dendritic tree analysis
Three-D reconstructions of representative Golgi-im-
pregnated neurons from CA1 were made. The criteria
used to select neurons for reconstruction were as
follows: (i) full impregnation of the neurons along the
entire length of the dendritic tree; (ii) dendrites
without significant truncation of branches; (iii)
relative isolation from neighboring impregnated neu-
rons to avoid interference with the analysis; (iv) no
morphological changes attributable to incomplete
dendritic impregnation of Golgi–Cox stain. Golgi-
impregnated pyramidal-like neurons of the CA1
region were readily identified by their characteristic
pyramidal or piriform soma, spine-sparse primary
dendrites and spine-dense secondary dendrites (Fig-
ure 2e for representative reconstructions). For each
selected neuron, all branches of the dendritic tree and
the location of all dendritic spines were reconstructed
at 600 magnification, using a motorized microscope
(Carl Zeiss Axioplan 2, Hamburg, Germany, with oil-
objectives), attached to a camera (DXC-390, Sony,
Tokyo, Japan) and Neurolucida software (Microbright-
field). Three-D analysis of the reconstructed neurons
was performed using NeuroExplorer software (Micro-
brightfield). In each hemisphere, 10 CA1 pyramidal
neurons were reconstructed; as a result in this study
we have analyzed 200 neurons. Several aspects of
dendritic morphology were examined. To assess
overall changes, total dendritic length, number of
ramifications and number of dendrites were com-
pared between groups. Sholl analysis was performed
to assess changes in the ramification pattern.
Electrophysiological recordings
After decapitation the brain was rapidly removed and
the hippocampi were dissected free in ice-cold Krebs
solution composed of (mM): NaCl 124; KCl 3;
NaH2PO4 1.25; NaHCO3 26; MgSO4 1; CaCl2 2; and
glucose 10, previously gassed with 95% O2 and 5%
CO2, pH 7.4. 400mM slices were obtained with a
McEwen tissue shopper and field excitatory post-
synaptic potentials (fEPSPs) were recorded as pre-
viously29 in stratum radiatum of the CA1 area. Input–
output (I/O) curves and long-term potentiation (LTP,
100Hz, 1 s, 100 pulses induced at 0.5mV/ms; < 50%
max) were recorded as previously. The second
hippocampus was rapidly frozen in liquid nitrogen
for further analysis.
Tissue processing
Samples were homogenized either in radio immuno-
precipitation-assay buffer (50mM Tris, 1mM EDTA,
Adenosine A2A receptor in stress-induced deficits
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150mM NaCl, 0.1% SDS, 1% NP 40, pH 8;38 or in
0.32M sucrose solution with 50mM Tris at pH 7.619
supplemented with protease inhibitors (ROCHE,
Mannheim, Germany). The first were centrifuged at
14 000 g for 15min, and the second at 1000 g for
10min, at 4 1C. The supernatant was collected,
corresponding to whole-tissue lysate and whole-
tissue homogenate, respectively. For membrane iso-
lation the whole-tissue homogenate was centrifuged
at 14 000 g for 12min, at 4 1C, the pellet is the
membrane fraction. Protein was quantified using the
BioRad Protein or DC Protein based on procedures
previously described.39,40
Saturation-binding assays
The radioligand-binding experiments were performed
as described41 with membrane fractions. Briefly,
[3H]ZM 241385 binding (0–10nM) was for 1h with
20–35mg of protein/well for striatum membranes and
[3H]DPCPX (0–10nM) binding was for 2h with
40–60mg protein/well of hippocampal, 60–100mg
protein/well of cortex and 20–40mg protein/well of
striatum membranes. Specific binding was deter-
mined subtracting the non-specific binding, measured
in the presence of 2mM of XAC and normalized for
protein concentration. Radioactivity was determined
after 12h with an efficiency of 55–60% for 2min. All
binding assays were performed in triplicate.
Immunoblotting
Lysates or homogenates were denatured with 5
sample buffer (350mM Tris pH 6.8, 30% glycerol, 10%
SDS, 600mM DTT and 0.012% Bromophenol blue, pH
6.8) and heated either at 951C for 5min or at 60–70 1C
for 30min, respectively, and further processed as
before.29 A2AR and GABAAR antibodies (Upstate/
Millipore, Temecula, CA, USA; 05–717 and 05–474)
were at 1:2000, GR, MR (Santa Cruz Biotechnology,
Heidelberg, Germany; sc-1004 and sc-11412) at 1:1000
and 1:200, NMDAR2B (Cell Signaling, Danvers, MA,
USA; D15B3) at 1:1000 and glutamate receptor one
(GluR1) (Millipore, 05–855) at 1:6000. Optical density
was determined with Image-J software and normalized
to the respective b-actin or a-tubulin band density.
Drugs
A2AR-selective antagonist, 2-(2-Furanyl)-7-(2-phenyl-
ethyl)-7H-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyri-
midin-5-amine (SCH58261) and the non-selective
adenosine receptor antagonist 8-(4-((2-minoethyl)
amino)carbonylmethyloxyphenyl)xanthine (XAC) were
purchased from Tocris Cookson, UK. These solutions
were diluted in the assay solution from 5mM stock
aliquots made in DMSO stored at 20 1C. A2AR-
selective antagonist, (E)-8-(2-(3,4-dimethoxyphenyl)-
vinyl)-1,3-diethyl-7-methyl-3,7-dihydropurine-2,6-dione
(KW6002, istradefylline) was synthesized according
to a published procedure.42 The purity of the product
was determined by HPLC analysis coupled to electro-
spray ionization mass spectrometry and was >98%.
Adenosine deaminase (from calf intestine 10mg/2ml,
EC 3.5.4.4) was from ROCHE; A1R-selective antago-
nist, (propyl-3H)8-cyclopentyl-1,3-dipropylxanthine
([3H]DPCPX, specific activity 100 Ci per mmol) was
from Amersham, Buckinghamshire UK, and A2AR-
selective antagonist, 4-(2-(7-Amino-2-(2-furyl)(1,2,4)-
triazolo(2,3-a) (1,3,5)triazin-5-ylamino)ethyl)phenol,
([3H]ZM 241385, specific activity 27.4 Ci per mmol)
was from ARC, St Louis, MO, USA. All these drugs
were diluted directly in the incubation solution each
day. HRP-coupled secondary antibodies were from
Santa Cruz Biotechnology. All other reagents used
were of the highest purity available either from Merck
or Sigma Aldrich, Madrid, Spain.
Statistics
Values presented are mean±s.e.m. of n experiments.
To test the significance of the differences between
CTR and MS groups, an unpaired Student’s t test was
used. When comparing CTR, MS, CTR KW and MS
KW groups a one-way ANOVAwas used, followed by
a Bonferroni’s Multiple Comparison post hoc test. For
the Sholl analysis of reconstructed neurons a repeated
measures analysis was used. For the saturation
binding curves an F-test was used to determine
whether the competition curves were best fitted by
one or two independent binding site equation and if
the parameters obtained from the CTR and MS
saturation curves (Bmax and KD) were different. For
the analysis of the MWM acquisition curve and
corticosterone circadian oscilation, the statistical
differences were evaluated using two-way ANOVA
repeated measures test. Values of P<0.05 were
considered to be statistically significant.
Results
MS induces long-lasting regional effects in the brain
MS induces numerous changes in the brain particu-
larly in the hippocampus.43,44 The balance between
mineralocorticoid and glucocorticoid receptors (MR
and GR, respectively) can determine the impact of
stress in different brain areas.45 We quantified the
levels of GR and MR in the hippocampus, cortex and
striatum of adult animals previously subjected to MS
(Figure 1a). MS has lead to a long-lasting decrease of
the GR levels that was more evident in the hippo-
campus (0.74±0.04 of CTR, n=8, P<0.05) than in
cortex (0.86±0.03 of CTR, n=4, P<0.05) or striatum
(0.90±0.03 of CTR, n=4; P<0.05). MR levels were
not modified in any of the brain areas analyzed
(Figure 1b). Concomitant changes on the levels of
adenosine receptors were observed. Comparing with
CTR, MS animals presented a 1.49±0.04-fold in-
crease (n=9; P<0.05) in the levels of A2AR that was
restricted to the hippocampus (Figure 1c). A hippo-
campal-specific decrease in the A1R levels was also
observed; Bmax values were of 1202±33 fmol per mg
protein (n=4) for CTR animals and 1073±23 fmol per
mg protein for MS animals, (n=4; P<0.05; Figure 1d).
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MS animals also presented a sustained increase in
plasmatic corticosterone levels (Figure 1e).
Adenosine A2A receptors are involved in synaptic
changes induced by MS
To evaluate the impact of stress in synaptic transmis-
sion and plasticity, fEPSPs were measured in the CA1
area of the dorsal hippocampus. Basal synaptic
transmission was accessed by performing I/O curves,
whereas synaptic plasticity was evaluated by LTP
induced by high frequency stimulation (100Hz, 1 s).
The I/O curve was not modified by MS (Figure 2a,
n=3). However, LTPmagnitude (Figure 2b) was reduced
in MS animals to 34.4±2.7% from 50.7±3.4% of
potentiation obtained in CTR (n=7, P<0.05).
To evaluate whether the increase in A2A adenosine
receptors was involved in the impairments observed in
synaptic plasticity, LTP was induced in the presence of
SCH58261 (50nM), a selective A2AR antagonist. The ex
vivo blockade of A2AR reverted the LTP deficits
induced by MS without affecting LTP magnitude in
CTR animals (53.1±3.7% and 57.3±1.7% of potentia-
tion, respectively, n=4–7, P>0.05; Figure 2c).
Moreover, the in vivo administration of the A2A-
selective antagonist KW6002 for 1 month to adult MS
animals was also able to revert the LTP deficits
observed (47.6±3.9% of potentiation in MS KW
animals, n=4, P>0.05 versus CTR; Figure 2d).
In order to better characterize the plastic changes
observed in the electrophysiological studies, a 3D
morphological analysis of dendritic arborizations of
CA1 pyramidal neurons was performed. Data revealed
a significant treatment effect in the total length of
apical dendrites of pyramidal neurons (F=7.371,
P<0.001), and in the total number of apical dendrite
ramifications (F=9.272, P<0.001); post-hoc analysis
showed that MS induced a significant decrease in the
total length of apical dendrites when compared with
CTR (P<0.05) (Figure 2e). Similarly, MS pyramidal
neurons had significantly less ramifications in apical
dendrites when compared with CTR (P<0.05). Both
parameters were restored by KW6002 treatment
(P>0.05 versus CTR). There were no significant
differences in the structure or number of basal
dendrites. Sholl analysis showed coherent changes
in the pattern of ramification (F=5.691, P<0.001).
The changes in apical dendrite arborizations
observed in MS animals when compared with CTR
(P<0.05) were reverted by KW6002 (Supplementary
Figure S2).
To further evaluate the consequences to the overall
morphology we undertook an estimation of hippo-
campal formation volumes. Our data revealed that
neither MS nor KW6002 treatment significantly
affected volumetric estimates (Supplementary
Table S1).
Figure 1 Region-specific effects of MS. MS induced region-specific changes in, GR (a) MR (b) A2AR (c) and A1R (d) and an
increase in plasmatic corticosterone levels (e). Protein levels of GR, MR (in all brain areas) and A2AR (in hippocampus and
cortex) were evaluated by western blotting. Specific immunoreactivity was normalized to that of b-Actin or a-tubulin. For
A2AR immunoreactivity 5mg of striatum were used as positive control. Results are the mean±s.e.m. of 3–9 experiments;
*P<0.05, comparing with CTR, calculated using an unpaired Student t-test. A1R levels in all areas and A2AR levels in
striatum were measured by saturation-binding curves with the A1 or A2A receptor selective antagonist [
3H]DPCPX or [3H]ZM
24135, respectively. [3H]DPCPX or [3H]ZM 24135 (7 nM) were incubated with 20–100 mg of membranes in a final volume of
300 ml for 2 h/1h at room temperature. The ordinates represent the specific binding obtained upon subtraction of the non-
specific binding, determined in the presence of 2 mM of XAC, from total binding. Values are the mean±s.e.m. of 4–5
experiments performed in triplicate. *P<0.05 calculated using an F-test compared with CTR. Corticosterone levels in the
morning period (8 am) were measured by radioimmunoassay using the rat corticosterone [3H] kit. Results are mean±s.e.m. of
nine experiments; *P<0.05 obtained using a unpaired Student t-test.
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Oral administration of a selective A2A receptor
antagonist reverts the stress-induced anxious
behavior and learning-deficits
We then evaluate the extent to which A2AR are
involved in the stress-induced behavior alterations,
by the administration of the A2AR-selective anta-
gonist, KW6002, to adult MS animals.
Anxious behavior and hippocampal-dependent
memory were evaluated by the EPM and the MWM
paradigms, respectively. In the EPM, MS animals
presented a higher anxious-related behavior
(spent less time in the open arms, 11.4±2.0% versus
28.9±5.3% in CTR, n=8–11, P<0.05), validating the
MS stress induction. The hyperanxious behavior in
MS animals was reverted upon treatment with
KW6002 (time in open arms: 27.3±4.4%, n=8,
P>0.05 versus CTR; Figure 3a). KW6002 treatment
by itself had no effect in the anxious behavior of CTR
Figure 2 Involvement of adenosine A2A receptors in the synaptic changes induced by MS. (a) I/O curves performed to
evaluate synaptic transmission in CTR and MS animals and (b) LTP (high frequency stimulation, 100Hz,1 s), used to evaluate
synaptic plasticity. Representative recordings of the fEPSPs obtained both for CTR and MS animals before LTP induction and
in the last 10min are presented. The effect of SCH58261 (50nM) application for 30min before LTP induction and throughout
the protocol is shown in (c). The outcome of KW6002 treatment upon LTP is in (d) with representative recordings of the
fEPSPs obtained for CTR, MS and MSþKW6002 animals, before LTP induction and 1h after LTP. Bar graphs are obtained by
making the average of the last five timepoints of each experiment. Results are the mean±s.e.m. of 3 (a) or 4–7 experiments
*P<0.05, comparing with CTR. (e) Administration of KW6002 reverses dendritic atrophy induced by MS in CA1 pyramidal
neurons. Upper panel depicts representative schematics of 3D reconstructions of CTR, MS, CTR KW and MS KW CA1
neurons. *P<0.05, comparing with CTR, #P<0.05, comparing with MS, calculated using a one-way ANOVA followed by a
Bonferroni’s Multiple Comparison Test.
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animals (26.5±3%, n=7, P>0.05), neither had an
impact in locomotor performance in EPM (Figure 3b).
On the MWM, the learning ability (Figure 3c) of MS
animals was impaired, so that at day three MS
performed worse than CTR animals (F(3,132) = 8.56,
n=6, P<0.0001). These deficits were reverted by
blocking A2AR in vivo (n=10, P<0.05). The retention
ability of MS animals was also compromised, as in the
probe test MS animals spent less time in the platform
quadrant than CTR (36.8±3.9%, n=8; P<0.05 versus
51.3±5.0%, n=7; Figure 3d). When treated with the
A2AR antagonist the retention ability of MS animals
was restored (52.8±4.2% of the time in the platform
quadrant; n=8, P>0.05; Figure 3d). KW6002 by itself
had no effect in the performance of CTR animals.
A2AR are highly abundant in striatum exerting
important effects in motor control.46 To evaluate
directly locomotor activity, the open-field arena test
was used. In accordance with data obtained in the
EPM, neither MS nor the KW6002 treatment induced
changes in the locomotor performance of the animals,
as no alterations were observed in the mean speed on
the open-field arena (Figure 3e).
Oral administration of a selective A2A receptor
antagonist re-establishes stress-induced modifications
on synaptic markers
Given the positive effects of the in vivo KW6002
treatment in behavior, in ex vivo synaptic plasticity
and in neuronal morphology, we next explored the
molecular changes that could underlie the observed
therapeutic effects. The levels of A2AR and GR were
measured in the hippocampus of CTR andMS animals
treated with KW6002. Given the role of AMPA,
GABAA and NMDA receptors in synaptic transmission
and plasticity, AMPA-GluR1, GABAA-b2/3 and
NMDAR2B subunits levels were also evaluated.
AMPA-GluR1 levels in MS animals were significantly
decreased comparing with CTR (0.81±0.02, n=9,
P<0.05; Figure 4a). These values were re-established
by KW6002 (0.98±0.03, n=4, P>0.05 versus CTR).
GABAA-b2/3 levels decreased in MS animals
(0.78±0.02, n=8; P<0.05; Figure 4b) and increased
to 1.15±0.06 of CTR (n=6, P<0.05) upon KW6002
treatment. The levels of the NMDAR2B subunit were
not altered by MS nor by KW6002 treatment (n=5;
Figure 4c). Furthermore, the increased levels of A2AR
observed in MS animals (1.49±0.04-fold to CTR, n=9;
P<0.05) were maintained in MS KW animals
(1.56±0.05-fold to CTR, n=5, P>0.05; Figure 4d).
The KW6002 administration alone increased the
levels of A2AR to 1.25±0.09 of CTR (n=5, P<0.01;
Figure 4d), as could be expected from a chronic
administration of receptor antagonist. The GR levels
(Figure 3e) were not changed by KW6002 in CTR
animals (n=7, P>0.05); however, when KW6002 was
administered to MS animals the levels of GR increased
to values similar to CTR (1.033±0.04, n=6, P>0.05).
Figure 3 Administration of KW6002 reverts the stress-induced anxious behavior and learning deficits. Anxious behavior
(a, b) and locomotor activity (e) were evaluated by the elevated-plus-maze-test and open-field, respectively. Hippocampal-
dependent memory performance was assessed by the MWM test, in which acquisition (c) and retention (d) were evaluated.
Results are the mean±s.e.m. of 6–9 animals; *P<0.05, comparing with CTR, #P<0.05 comparing with MS, calculated using
two-way ANOVA repeated measures (a) or one-way ANOVA followed by a Bonferroni’s Multiple Comparison Test.
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The A2AR antagonist re-establishes the corticosterone
circadian oscillation
As the blockade of A2AR reestablishes the GR levels in
the hippocampus, we hypothesized that this could
involve a regulation of the HPA-axis function, which
is compromised due to the early life stress.14 HPA-axis
activity was evaluated by measuring circadian
changes in plasmatic corticosterone levels (Figure 5).
CTR animals had the expected circadian oscilla-
tion, with corticosterone levels significantly elevated
at 8 pm comparing with those measured at 8 am MS
animals present significantly higher corticosterone
levels already at 8 am (234±13ngml–1 versus
142±27ngml–1; P<0.05, n=9) comparing with CTR
at the same time of the day, and the absence of a
circadian oscillation. Animals treated with KW6002
had a restored circadian variation, with plasmatic
corticosterone levels at 8 am similar to CTR
(63±5ngml–1), (F(3,24) = 9.04, P=0.0003). KW6002
alone did not affect corticosterone levels, neither at
zenith nor at nadir.
Discussion
The data now reported reveal that adenosine A2A
receptor activation is directly involved in the stress
deleterious effects in the brain. We show, for the first
time, that the administration of a selective adenosine
A2A receptor antagonist reverts the long-lasting con-
sequences of stress on spatial memory, synaptic
plasticity and neuronal morphology in the hippocam-
pus. Moreover, our data indicate that these effects are
Figure 4 Administration of KW6002 reverts the synaptic changes induced by MS. The effects of the treatment with KW6002
in the levels of GluR1 subunit of AMPA receptors (a), b2/3 subunit of GABAA receptors (b), NMDAR2B (c), A2AR (d), and GR
(e) were evaluated by western blotting. Specific immunoreactivity normalized to that of a-tubulin. Results are the
mean±s.e.m. of 4–9 experiments; *P<0.05, comparing with CTR and #P<0.05, comparing with MS, calculated using a one-
way ANOVA followed by a Bonferroni’s Multiple Comparison Test.
Figure 5 The KW6002 administration re-establishes the
corticosterone circadian oscillation. Corticosterone levels in
the plasma measured at nadir and zenith. Results are mean
of 6–9 animals.*P<0.05, comparing with CTR, #P<0.05
comparing with MS, fP<0.05, comparing with am values,
calculated using a one-way ANOVA followed by a Bonfer-
roni’s Multiple Comparison Test.
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associated with the re-establishment of the HPA-axis
activity.
An imbalance in adenosine receptors has been
observed in multiple conditions,21 particularly with
progressive aging,18,19 which has consequences to
their modulatory effects.19,41 In the aged rat brain,
adenosine A1 receptor density is decreased,
47 parti-
cularly in hippocampus and cortex.18 However, A2A
receptor levels are differently affected: they decrease
in striatum, but in contrast there is an increase in
their expression in cortical and hippocampal areas.18
As we now show, the changes in adenosine receptor
levels induced by MS, follow a close pattern to the
one occurring in the aged brain, that is, an increase in
A2A and a decrease in A1 receptor levels. The
modifications observed are, however, restricted to
the hippocampus, probably due to the changes in GR
levels that are more profound in this brain area. Thus,
as observed in aging,19,48 MS induces a decrease in GR
levels, increasing the MR/GR ratio, an increase in
plasma corticosterone levels and changes in adeno-
sine receptor levels. Thereupon our data reinforce the
hypothesis that stress is associated with an early
aging in the hippocampal area.2,49 Different brain
regions have a distinct vulnerability to stress due to
the differential expression of GR and MR in the
brain.50 In the hippocampus, corticosterone is able to
trigger signaling pathways activated by both GR and
MR due to their particular high-affinity ratio for GR,
which does not occur in other brain areas.50 This
confers to the hippocampus a particular susceptibility
to stress effects and consequent deficits. Additional
region-specific effects were reported previously, such
as alterations in GABAA receptor levels and MAP
kinase activity.51,52
We have observed a sustained increase in the
plasmatic levels of corticosterone, a feature that is
also shared with ageing.53 Such an increase is usually
associated to a downregulation in GR,11,54,55 as a way
to limit their action. This is generally an isolated and
reversible effect, reverted whenever the plasma levels
of corticosterone return to baseline.55 However, as we
show, MS animals exhibit elevated plasma corticos-
terone levels throughout life and an associated
sustained downregulation of GR in the hippocampus.
These receptors regulate memory and synaptic plas-
ticity.45,56 Accordingly, we found that LTP is impaired
in MS animals and this is accompanied by a poorer
performance in a spatial memory task, the MWM. The
observed changes in synaptic plasticity can be related
to the altered levels in GABAA and AMPA receptors,
reported here. Others have described that MS induces
a decrease in markers of synaptic plasticity, such as
NCAM or synaptophysin,43 as well as in the levels of
NMDAR2B, AMPAGluR1 and GluR244 in the hippo-
campus. Changes now observed in glutamate receptor
levels had, however, no impact upon basal synaptic
transmission, possibly because they are accompanied
by a decrease in GABAA receptors, which will result
in a final compensatory balance in order to maintain
homeostasis.
The observed impairments in LTP were overcome
by blocking adenosine A2A receptors. These receptors
are known to have stimulatory effects on basal
synaptic transmission in the hippocampus17,41 by
promoting glutamate release,57 and were recently
shown to potentiate LTP when exogenously acti-
vated.58 The protective effect of administering A2A
receptor antagonists in vivo has already been de-
scribed.21 By contrast, we have observed before that,
in particular conditions, the acute treatment of slices
with SCH58261 may instead cause a LTP drop. This is
particular to overexcitability conditions, such as
ageing, in which LTP is enhanced29,59 due to an age-
induced shift in A2A receptor signaling.
19,41 However,
in more chronic patho-physiological situations, in
which LTP is decreased, the SCH58261 is able to
promote its restoration,60 in accordance with what we
now report for stress-induced deficits.
More importantly, the chronic administration of a
selective antagonist, KW6002, for 1 month, clearly re-
established the MS-driven impairment in LTP. How-
ever, the A2A receptor antagonist did not alter LTP in
CTR animals, whereas clearly promoting the recovery
of the impaired LTP, but only in MS animals. This
suggests that, rather than having a direct effect on
glutamatergic transmission, A2A receptors may be
instead modulating the GR-mediated effects. Indeed,
we have recent data showing the ability of A2A
receptors to influence GR transcriptional activity
and nuclear translocation.61 Thus, the chronic block-
ade of A2A receptor may decrease GR transcriptional
activity and thereby the overall GR-driven effects.
Genetic deletion of A2A receptors affects anxiety
and aggressive behavior,62 and this constituted the
first evidence that A2A receptors could be implicated
in stress. The subsequent report that A2A receptor
antagonists applied before and during a single
episode of acute stress prevented synaptic loss,22
suggested that A2A receptors overactivation could
underlie the genesis of stress-induced changes. None-
theless, the question whether this overactivation is a
consequence of the stress paradigm or a triggering
factor to the observed deficits has never been
addressed before.
We now explored the possibility that blocking the
action of A2A receptors would restore pre-existing
stress-associated impairments. The advantage of
using KW6002 over other antagonists for A2A recep-
tors is its enhanced bioavailability, permeability to
the brain blood barrier, having a longer half-life and
high affinity and selectivity towards A2A receptors.
27
Additionally, KW6002 has undergone clinical trials
for Parkinson’s and therefore its safety has been
established.63 We now report that oral administration
of KW6002, for 1 month, to adult animals previously
subjected to MS, reestablishes impaired hippocam-
pal-dependent memory, synaptic plasticity and
morphology, and reverts the anxious behavior. The
learning ability of MS animals was restored by the
treatment, as well as the retrieval, evaluated by
the time spent in the previous retained platform
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quadrant. This is associated with a re-establishment
of the hippocampal CA1-induced LTP. The insertion
of AMPA receptors containing GluR1 subunit is a
constitutive part of LTP induction64 and is modulated
by GR.65 We found that GluR1-subunit is decreased by
MS, which may explain the decreased LTP. Moreover,
the LTP re-establishment is accompanied by a con-
comitant restoration of GluR1 levels upon KW6002
treatment. Accordingly, MS leads to a decrease in
apical dendritic length, as described using other
stress models,66 but this structural effect is reverted
by the blockade of A2A receptors.
The HPA-axis maintains the physiological circa-
dian oscillation of corticosterone levels, which reach
their maximum at zenith (8 pm) and the minimum at
nadir (8 am), for rodents.67 The hippocampus is
crucial in the negative feedback required to limit
HPA-axis activation, particularly in stressful situa-
tions.1,2 However, this function can be compromised
when glucocorticoid levels are persistently high as in
chronic stress, aging or in psychopathologies.48 The
observation that the A2A receptor antagonist was able
to re-establish the decreased GR levels in the
hippocampus lead us to test whether the observed
effects were related to a modification of the HPA axis,
by measuring the circadian levels of corticosterone in
plasma. MS animals present not only higher plas-
matic levels of corticosterone, but also an impaired
circadian fluctuation. Corticosterone levels were
chronically higher in MS animals and did not
decrease along the night. This is probably associated
to an impaired inhibition of the HPA-axis, which is
consequence of a decrease in hippocampal GR levels.
Interestingly, by blocking A2A receptors, the basal
levels of corticosterone were re-established, so as the
circadian rhythm and the GR levels in the hippocam-
pus. Altogether, these data suggest that A2A receptors
have a role in the regulation of the HPA-axis, either
directly or by regulating hippocampal function. This
effect may be due to interference with the release of
corticotrophin-releasing hormone, adrenocorticotro-
phin, which is known to be affected by adenosine,68
or by modulating glucocorticoids. The beneficial
effect resulting from A2A receptor antagonism may
derive instead from a re-establishment of hippocam-
pal excitability, which in turn would restore the
inhibitory tonus onto the HPA-axis. Overall, the
blockade of adenosine A2A receptors by KW6002 has
a beneficial effect in overcoming the hippocampal-
related deficits induced by MS. Interestingly, this
effect of KW6002 in vivo does not result from a
decrease in A2AR levels, which remain high in MS
animals under KW6002. Indeed, it would be unlikely
that KW6002 would cause a decrease in A2AR levels
as prolonged blockade of receptors usually leads to
either no change or upregulation of receptor levels
due to compensatory mechanisms following restrain-
ing from receptor activation by the endogenous
ligand. Remarkably, the findings that blockade of
A2AR overcomes the synaptic and memory deficits
associated to MS, strongly suggests that A2A receptors
overactivation is the cause rather than the conse-
quence of the herein reported changes associated with
chronic stress.
In conclusion, our results show, for the first time,
that the changes induced by stress are reverted by the
in vivo blockade of A2A receptors. Moreover, they
imply a role of A2AR in the HPA-axis regulation
revealing that its blockade is efficient in re-establish-
ing the compromised HPA-axis, which has clinical
implications for the treatment of psychopathologies.
This provides a potential alternative to the estab-
lished therapies against stress-related pathologies, by
targeting a modulatory system rather than interfering
directly with neurotransmitters, and thereby limiting
the associated side-effects.
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